LCTX Chart
- 52-Week Range: $1.12 - $3.00
- Market Capitalization: $203.67M
- Short Percentage: 0%
- Target Price: $6.40
- Shares Outstanding: 169.73M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
LCTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Lineage to Present at the NobleCon18 Investor Conference on April 20, 2022Business Wire | April 11th
- Lineage to Present at B. Riley Securities 2022 Virtual Oncology Conference on January 27, 2022Business Wire | January 24th
- Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®Business Wire | November 30th
- Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 10th
- Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021Business Wire | September 20th
- Lineage Cell Therapeutics' (LCTX) CEO Brian Culley on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 12th
Company Info
Website: https://www.lineagecell.com
Address: 2173 Salk Avenue, Carlsbad, CA, United States, 92008
Sector: Healthcare
Industry: Biotechnology
Full time employees: 57
Address: 2173 Salk Avenue, Carlsbad, CA, United States, 92008
Sector: Healthcare
Industry: Biotechnology
Full time employees: 57
$LCTX a comeback is always more fun than an all out win!!!!
$LCTX do what the markets tells you to do not the other way around
$LCTX due for a spike!
$LCTX good place to average up
$LCTX the catalyst we need !
$LCTX good place to average up
$LCTX can't get enough